IGC Pharma, Inc. (IGC)
Develops drugs to treat Alzheimer's disease and dementia-related agitation.
$0.26-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-23.8%
The outlook
IGC is trading near the bottom of its 52-week range and sits below both its 50- and 200-day moving averages, reflecting a weak price trend. Analyst coverage appears thin, and the overall sentiment leans heavily bearish. The stock is in a depressed position relative to its recent performance.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.50
52-wk low
$0.24
50-day avg
$0.28
200-day avg
$0.31
Trailing P/E
—